TY  - JOUR
A1  - Wiegand, Steffen B.
A1  - Heidrich, Benjamin
A1  - Susser, Simone
A1  - Rogalska-Taranta, Magdalena
A1  - Petersen, Jörg
A1  - Böker, Klaus H. W.
A1  - Grigorian, Natalia
A1  - Link, Ralph
A1  - Naumann, Uwe
A1  - John, Christine
A1  - Lüth, Stefan
A1  - Malfertheiner, Peter
A1  - Manns, Michael P.
A1  - Wedemeyer, Heiner
A1  - Sarrazin, Christoph
A1  - Cornberg, Markus
T1  - Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting
T2  - PLoS One
N2  - Background: SNPs near the interferon lambda (IFNL) 3 gene are predictors for sustained virological response (SVR) in patients with chronic hepatitis C genotype (GT) 1. In addition, a dinucleotide frame shift in ss469415590 was described, which generates IFNL4. In this study, we compared the role of IFNL4 variants with IFNL3-(rs12979860) and IFNL3-(rs8099917) on response to pegylated (PEG)-IFN and Ribavirin (RBV) in patients with chronic hepatitis C GT2/3.
Methods: We recruited 1006 patients with chronic hepatitis C and GT2/3 in a large German registry. A treatment with PEG-IFN and Ribavirin was started by 959 patients. We performed genotyping of IFNL3 (rs12979860, n = 726; rs8099917, n = 687) and of IFNL4 (ss469415590; n = 631).
Results: Both preferable IFNL3 genotypes were associated with RVR (both p<0.0001) rather than with SVR (rs12979860: p = 0.251; rs8099917: p = 0.447). Only RVR was linked to SVR in univariate and multivariate analyzes (both p<0.001). Concordance of genotyping in patients with available serum samples and EDTA blood samples (n = 259) was more than 96% for both IFNL3 SNPs. IFNL3-(rs12979860) correlated with IFNL4: 99.2% of patients with IFNL3-(rs12979860)-CC were IFNL4-(ss469415590)-TT/TT. IFNL3-(rs12979860)-CT was linked with IFNL4-(ss469415590)-TT/ΔG (98.0%) and IFNL3-(rs12979860)-TT was associated with IFNL4-(ss469415590)-ΔG/ΔG (97.6%).
Conclusion: IFNL3 genotyping from serum was highly efficient and can be used as an alternative if EDTA whole blood is not available. In Caucasian GT2/3 patients genotyping for INFL4-(ss469415590) does not lead to additional information for the decision-making process. Importantly, IFNL3 SNPs were not associated with SVR but with RVR. Even in the era of new direct acting antiviral (DAA) therapies, IFNL3 testing may therefore still be considered for naïve GT2/3 patients to decide if dual Peg-IFN/RBV therapy is an option in resource limited regions.
Y1  - 2015
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/39037
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-390374
SN  - 1932-6203
N1  - Copyright: © 2015 Wiegand et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
VL  - 10
IS  - (12): e0145622
SP  - 1
EP  - 15
PB  - PLoS
CY  - Lawrence, Kan.
ER  -